Because bone and joint damage occur later in the course of the disease, X-rays may not be very useful in detecting RA in the early stages, although soft tissue swelling around a joint can be seen on a regular X-ray
No Proper Information There is no accurate information available about its usage for pregnant and breastfeeding mothers
[10] It is worth being exact about what that source says, because the naive reading goes too far in the other direction: the recommendation is to adjust the parenteral copper dose according to serum concentrations and the clinical picture, explicitly not to stop it, since discontinuing copper in cholestatic patients risks producing copper deficiency instead
A lot of people are speaking with absolute certainty when the truth is that the FDA landscape around peptides has been shifting rapidly since 2023, and especially throughout 2025 and 2026
The SURPASS clinical trial program, which evaluated tirzepatide in patients with type 2 diabetes, documented injection site reactions as generally mild to moderate in severity
- , -
